PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma

Figure 8

The correlation of PLEKHA4 expression with PD-1, PD-L1, CTLA-4, and TIM-3 expression in glioma. (a) Spearman’s correlation of PLEKHA4 with expression of PD-1 in glioma adjusted by purity using TIMER. (b) Spearman’s correlation of PLEKHA4 with expression of PD-L1 in glioma adjusted by purity using TIMER. (c) Spearman’s correlation of PLEKHA4 with expression of CTLA-4 in glioma adjusted by purity using TIMER. (d) The expression correlation of PLEKHA4 with TIM-3 in glioma adjusted by purity using TIMER. (e) The expression correlation of PLEKHA4 with PD-1 in glioma determined by GEPIA database. (f) The expression correlation of PLEKHA4 with PD-L1 in glioma determined by GEPIA database. (g) The expression correlation of PLEKHA4 with CTLA-4 in glioma determined by GEPIA database. (h) The expression correlation of PLEKHA4 with TIM-1 in glioma determined by GEPIA database (ns, ; ; ; ).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)